Beyond Air
Yahoo Finance • 5 days ago
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
GARDEN CITY, N.Y., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) t... Full story
Yahoo Finance • 19 days ago
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) t... Full story
Yahoo Finance • 19 days ago
Top movers analysis one hour before the close of the markets on 2025-09-08: top gainers and losers in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT RAPP [ht... Full story
Yahoo Finance • 19 days ago
Curious about the most active stocks on Monday?
Curious about the most active stocks on Monday? Find out which stocks are dominating the market action! [mostactive] TOP MOST ACTIVE STOCKS TICKER CHANGE COMMENT OPEN [https://www.chartmill.com/stock/quote/OPEN/profile] 1.9... Full story
Yahoo Finance • 19 days ago
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. [topmovers] TOP GAINERS TICKER CHANGE COMMENT RAPP [https://www.chartmill.com/stock/quote/RAPP/profile] 111.0%... Full story
Yahoo Finance • 19 days ago
Let's uncover which stocks are experiencing notable gaps during today's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. [gap] GAP UP STOCKS TICKER CHANGE COMMENT XAIR [https://www.chartmill.com/stock/quote/XAIR/profile] 88.24%... Full story
Yahoo Finance • 19 days ago
Top movers in Monday's pre-market session
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT HOUR [https://www.ch... Full story
Yahoo Finance • 24 days ago
Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GARDEN CITY, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) t... Full story
Yahoo Finance • last month
Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan
GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to... Full story
Yahoo Finance • 2 months ago
Beyond Air secures national purchasing agreement with Premier
GARDEN CITY, N.Y. - Beyond Air, Inc. (NASDAQ:XAIR), a medical device company with a market capitalization of $15.4 million and impressive revenue growth of 220% over the last twelve months, has been awarded a national group purchasing agre... Full story
Yahoo Finance • 2 months ago
Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.
GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to... Full story
Yahoo Finance • 3 months ago
Beyond Air to implement 1-for-20 reverse stock split effective July 14
Beyond Air, Inc. (NASDAQ:XAIR), currently trading at $0.21 with a market capitalization of $19.5 million, will implement a 1-for-20 reverse stock split of its issued and outstanding common shares, effective at 12:01 a.m. Eastern Time on Ju... Full story
Yahoo Finance • 3 months ago
Beyond Air shareholders approve reverse stock split authorization
Beyond Air, Inc. (NASDAQ:XAIR) announced that shareholders have approved a proposal authorizing the company’s board of directors to implement a reverse stock split of its common stock at a ratio between 1-for-10 and 1-for-50. The approval... Full story
Yahoo Finance • 3 months ago
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
LungFit PH II’s smaller, lightweight, transport-ready design is expected to open the entirety of the NO market Final design based upon substantial feedback from respiratory therapists across the country GARDEN CITY, N.Y., June 16, 2025... Full story
Yahoo Finance • 4 months ago
Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast
GARDEN CITY, N.Y., May 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to... Full story
Yahoo Finance • 5 months ago
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism
The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidatefor treating ASD in 2026 BOSTON,... Full story
Yahoo Finance • 5 months ago
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (N... Full story
Yahoo Finance • 6 months ago
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home
GARDEN CITY, N.Y., April 09, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) t... Full story
Yahoo Finance • 6 months ago
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site
GARDEN CITY, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) t... Full story
Yahoo Finance • 6 months ago
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
First-in-human studies anticipated to begin in 2026 Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of quality Currently in the advanced stages of formulation development for subcutaneous injection, wi... Full story
